News
-
May 22, 2017
miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically
The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry perspective on the state of the science and preclinical and clinical experiences with mi-R122. This webinar was hosted by PSTC’s Hepatoxicity Working Group. The first presentation discussed the current state of miR-122 as a safety biomarker of liver... - April 18, 2017
-
April 11, 2017
PTC Meets Its Deliverables
April 11, 2017 Dear Colleagues, In the fall of 2015 C-Path established the Pediatric Trials Consortium (PTC), with the goal of supporting the formation of a new, independent nonprofit organization that would develop a network of clinical trial sites with the specific capability to conduct registration-quality clinical trials for new medical products for children.... - April 5, 2017
-
March 24, 2017
For Two Arizona-Based Nonprofits, Past Meets Present on World TB Day
On March 24, the world will recognize the 35th annual observance of World Tuberculosis (TB) Day. The leading cause of death by an infectious disease, TB kills 1.8 million people per year, according to the World Health Organization (WHO). Even more worrying is the increase in the number of strains of the bacteria Mycobacterium tuberculosis...
